Lemaitre Vascular (LMAT) Tops Q3 EPS by 3c

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $19 million versus the consensus estimate of $18.8 million.

Lemaitre Vascular sees FY2015 revenue of $78.0 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24